Re-signalling the Blues: How Tadalafil Might Accelerate Antidepressant Response in Major Depressive Disorder Introduction: A New Angle on Antidepressant Acceleration Major depressive disorder (MDD) remains one of the most prevalent and disabling psychiatric conditions worldwide. Despite advances in pharmacotherapy, most first-line treatments, particularly selective serotonin reuptake inhibitors (SSRIs), require several weeks to take effect, and…

Antipsychotics Beyond Dopamine: The Muscarinic Turn Medically reviewed by Paul E. Bebbington, MA, MPhil, FRCPsych; Phern-Chern Tor, MBBS; and Pichet Udomratn, MD | Last updated: 12 June 2025 Introduction For more than half a century, antipsychotic treatment has rested on the pharmacological foundation of dopamine D2 antagonism: the idea that attenuating hyperdopaminergic signaling in striatal circuits would quell hallucinations,…

Safety, Adverse Events, Interactions & Abuse Potential of Gabapentin Zhen Wang1 ✉, Mei Li2 1Department of Pharmacology, Peking University, Beijing, China 2School of Pharmacy, Fudan University, Shanghai, China Abstract Gabapentin is widely prescribed for a range of conditions, including neuropathic pain, epilepsy, and anxiety disorders. While its therapeutic benefits are well-established, concerns regarding its safety, adverse effects, drug…

Abilify Side Effects: Comprehensive Review of Short- and Long-Term Risks Common Abilify Side Effects: Nausea, Insomnia, Restlessness The most frequently reported side effects of Abilify (aripiprazole) are generally mild to moderate in severity and often emerge within the first weeks of treatment. According to pooled data from FDA registration trials, the most common adverse drug…

Abilify Dosage Guide: Evidence-Based Oral and Long-Acting Regimens Approved Abilify Dosages by Indication (Schizophrenia, Bipolar I, MDD Augmentation, Autism Irritability, Tourette) Abilify (aripiprazole) is approved for multiple psychiatric indications, each with specific dosing recommendations based on clinical trial data and regulatory guidance. For adults with schizophrenia, the typical starting abilify dose is 10 mg or…

Abilify Withdrawal Symptoms and Timeline: An Evidence-Based Review Pathophysiology of Abilify Withdrawal Withdrawal from Abilify (aripiprazole) is primarily mediated by neuroadaptive changes in dopaminergic and serotonergic pathways. As a partial agonist at dopamine D2 and serotonin 5-HT1A receptors, aripiprazole modulates neurotransmission in a unique manner compared to full antagonists. Upon abrupt discontinuation, the sudden loss…

Managing SSRI-Induced Sexual Dysfunction: A Science-Based Guide Selective serotonin reuptake inhibitors (SSRIs) are among the most commonly prescribed antidepressants worldwide. While they are effective for treating depression and anxiety, a significant number of patients experience sexual side effects—sometimes severe enough to impact quality of life or lead to discontinuation of treatment. This article provides a…

Generic Abilify Cost: Price Comparison and Savings Strategies By Ju Zhang, MD — Los Angeles County Department of Mental Health, Los Angeles CA, USA | Kyooseob Ha, MD PhD — Seoul National University, Seoul, South Korea What Is Generic Abilify and How Does FDA Equivalence Work? Generic Abilify refers to aripiprazole, an atypical antipsychotic medication…

Abilify vs Other Antipsychotics: Comparative Efficacy, Side Effects and Weight Gain Risk Abilify vs Seroquel: Sedation, Metabolic Profile and Off-Label Uses The comparison of abilify vs seroquel (quetiapine) is clinically relevant due to their widespread use in schizophrenia, bipolar disorder, and off-label indications such as insomnia and anxiety. Aripiprazole is a partial dopamine D2 agonist,…

Abilify Long-Acting Injection (LAI): Clinical Review of Monthly and Two-Month Formulations Abilify Maintena 400 mg: Indications, Pharmacokinetics and Administration Technique Abilify Maintena 400 mg is a long-acting injectable (LAI) formulation of aripiprazole, approved for the maintenance treatment of schizophrenia in adults and as a maintenance option for bipolar I disorderKane 2019. The monthly injection delivers…